Appetite scoring: catching tolerance or rebound early
Weight loss on GLP-1 is downstream of appetite suppression — and appetite changes much faster than the scale does. A simple 1–5 score recorded at each meal catches the earliest signs of dose tolerance or unexpected appetite return, weeks before the weight curve flattens.
The scoring scale
| Score | Appetite / fullness state |
|---|---|
| 1 | No hunger; eating is effortful or unappetizing |
| 2 | Mild hunger; small portion satisfies |
| 3 | Normal hunger; appropriate portion satisfies |
| 4 | Strong hunger; might want seconds |
| 5 | Ravenous; would over-eat if allowed |
Rate at each meal, before eating, taking 2–3 seconds. Record the score. Over a week, average the daily scores.
Typical curve over a GLP-1 titration
Plotting weekly average appetite over a GLP-1 titration looks like this for most users:
- Week 0 (pre-drug): average 3.5–4.5 (normal hunger).
- Week 1 of new dose: drops to 2.0–2.5 (strong suppression, sometimes unpleasantly low).
- Weeks 2–4 of new dose: recovers slightly to 2.0–3.0 (effective suppression, eating without effort).
- Stable maintenance dose: stays around 2.5–3.5 for months.
What "tolerance" looks like
Tolerance — where the same dose produces less appetite suppression over time — shows up in appetite scoring before it shows on the scale:
- Stable dose for 3+ months, appetite score gradually climbing from 2.5 to 3.5 to 4.0 over weeks.
- Subjective return of food cravings, reflected in the score.
- Weight loss slows or plateaus 2–4 weeks after the appetite score starts climbing.
True pharmacological tolerance to GLP-1 over months is debated; some of what users perceive as tolerance may be receptor adaptation, dose drift (in compounded products), or behavioral adaptation. The scoring captures the perceived effect regardless of mechanism.
What "rebound appetite" looks like
Sudden appetite return — over days, not weeks — usually indicates something specific:
- Missed dose past the rescue window. Appetite climbs 24–48 hours after the would-have-been injection.
- Drug stopped or switched. Plasma decay over 2–4 weeks, appetite climbing through that window.
- Counterfeit or under-dosed product. Suddenly hungry after switching to a new pen or vial — see spotting counterfeit pens.
- Hormonal cycle or stress event. Transient appetite increase, returns to baseline within 1–2 weeks.
Using the score for dose decisions
Should I advance the dose?
- Weekly avg ≤2.5 at minimum 4 weeks on current dose: well-controlled appetite. Advance per titration schedule.
- Weekly avg 2.5–3.5: moderate control. Consider holding another week or two before advancing.
- Weekly avg >3.5: appetite climbing. Advance on schedule if titration ladder allows, or evaluate why the current dose isn't holding.
Should I hold the dose?
- Weekly avg ≤1.5 (too suppressed): hold current dose; you may be over-suppressed and risk under-eating.
- Weight loss exceeding 2 lb/week on average: hold or even step down to slow the pace.
The food-relationship signal
Appetite scoring also catches the qualitative shift in food relationship that GLP-1 produces:
- Pre-drug: meal anticipation is a meaningful part of the day, even pleasant.
- Effective dose: meals become more functional; pleasure from food doesn't disappear but is dampened.
- Tolerance creeping in: meal anticipation returns; specific food cravings return.
- Off-drug: full return of appetite, often briefly amplified compared to pre-drug baseline.
Tracking the score makes these phase transitions visible.
What the score doesn't catch
- Reward-driven eating (hedonic). Some users have suppressed hunger but persistent food-reward seeking. The score doesn't distinguish.
- Late-evening cravings. Mealtime scoring misses cravings that come at non-meal times.
- Emotional eating. Stress, boredom, social cues — these can produce eating despite low appetite scores.
The score is one signal in a richer picture. Combine with weight trend, meal protein, and overall well-being.
Practical implementation
- Set a reminder for each meal time. 30 seconds of scoring per meal.
- Score before eating, not after. Post-meal "I'm too full to eat more" is a different signal than pre-meal hunger.
- Track for at least 8 weeks to see the curve.
- Review weekly and tag any score that's very high or very low for explanation.
- Use the trend in dose decisions alongside weight and side-effect data.
FAQ
What if I forget some meal scores?
Gaps are fine. The weekly average is still meaningful with 60–80% of meals scored. Don't backfill from memory.
Does appetite score correlate with weight loss?
Loosely. Lower appetite scores correlate with more weight loss on average, but individual variability is high. Use it as one signal, not the only one.
Should I score by hunger or fullness?
Pre-meal hunger is cleaner. Post-meal fullness is harder to standardize because it depends on what you ate. Stick with pre-meal hunger.
Is appetite return after months a sign to switch drugs?
Possibly. Persistent return at maximum dose can mean it's time to try a different drug class (semaglutide → tirzepatide, or add cagrilintide if/when available). Discuss with the prescriber.
Related reading
Score appetite at each meal
Peptide Protocol logs appetite per meal, charts the weekly trend, and flags tolerance signals before they show on the scale.
Get the iPhone app →Informational and educational only. Not medical advice. Consult a licensed clinician before starting, changing, or stopping any peptide protocol. Mentions of investigational, compounded, or research-use peptides are for informational purposes; many such substances are not FDA-approved for human use.